About AstraZeneca
AstraZeneca (LSE:AZN), (NASDAQ:AZN), (NASDAQSTOCKHOLM:AZN) operates globally in the pharmaceutical and biopharmaceutical sector, focusing on the discovery, development, and commercialization of prescription medicines. The company's activities span a broad range of therapeutic areas, including oncology, cardiovascular, renal & metabolism, and respiratory & immunology, aiming to address significant unmet medical needs. AstraZeneca is known for its projects that push the boundaries of science to deliver life-changing drugs, with objectives centered around improving the health outcomes of millions of people worldwide. A cornerstone of its strategy involves robust research and development, strategic collaborations, and the integration of innovative technologies to enhance its pipeline and accelerate delivery of medical breakthroughs to patients.
Snapshot
Operations
Produtos e/ou serviços de AstraZeneca
- Oncology treatments, including innovative therapies for various types of cancer.
- COVID-19 vaccine, developed in collaboration with the University of Oxford.
- Respiratory & Immunology solutions, addressing diseases like asthma and COPD.
- Cardiovascular, Renal, and Metabolism portfolio, aimed at combating related conditions.
- Neuroscience research, focusing on treating diseases such as Parkinson's and Alzheimer's.
- Infection and vaccines development, beyond COVID-19, to tackle global health challenges.
equipe executiva do AstraZeneca
- Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.CEO & Executive Director
- Dr. Aradhana Sarin M.D.CFO & Executive Director
- Ms. Pam P. ChengEVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board
- Mr. Andrew P. BarnettHead of Investor Relations
- Mr. Jeffrey Pott J.D.CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board
- Dr. Ruud Dobber Ph.D.Executive Vice-President of BioPharmaceuticals Business Unit
- Dr. Susan Mary Galbraith M.D., Ph.D.Executive Vice President of Oncology R&D
- Ms. Iskra ReicExecutive Vice President of International
- Mr. David FredricksonExecutive Vice-President of Oncology Haematology Business Unit
- Ms. Ruth MarchSenior VP of Precision Medicine - R&D Oncology